Robnik, B.; Likozar, B.; Wang, B.; Stanić Ljubin, T.; Časar, Z.
Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin. Pharmaceutics 2019, 11, 452.
https://doi.org/10.3390/pharmaceutics11090452
AMA Style
Robnik B, Likozar B, Wang B, Stanić Ljubin T, Časar Z.
Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin. Pharmaceutics. 2019; 11(9):452.
https://doi.org/10.3390/pharmaceutics11090452
Chicago/Turabian Style
Robnik, Blaž, Blaž Likozar, Baifan Wang, Tijana Stanić Ljubin, and Zdenko Časar.
2019. "Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin" Pharmaceutics 11, no. 9: 452.
https://doi.org/10.3390/pharmaceutics11090452
APA Style
Robnik, B., Likozar, B., Wang, B., Stanić Ljubin, T., & Časar, Z.
(2019). Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin. Pharmaceutics, 11(9), 452.
https://doi.org/10.3390/pharmaceutics11090452